Literature DB >> 26318305

Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.

Na Shen1, Xinsheng Huang1, Jun Li2.   

Abstract

microRNA-129-5p may have a relationship with laryngeal squamous cell carcinoma (LSCC), but the expression and function of miRNA-129-5p are not fully understood. This study was performed to investigate the expression and function of miRNA-129-5p in LSCC and its effects on STAT3. HBE and Hep-2 cells were cultured and analyzed by western blotting and real-time PCR. miR-129-5p expression was detected by real-time PCR. Hep-2 cells were transfected with a miR-129-5p expression vector. Cell proliferation, invasion, migration, cell cycle, and apoptosis assays were used to determine the role of miRNA-129-5p in the growth, invasion, and migration of LSCC cells and to determine the importance of STAT3 in these effects. STAT3 mRNA expression in Hep-2 cells was significantly higher than that in HBE cells (P < 0.05). miR-129-5p expression detected by real-time PCR showed that it was expressed at a lower level in Hep-2 cells than in HBE cells (P < 0.05). Compared with the control cells, the transfected cells showed lower STAT3 mRNA expression. For up to 7 days in culture, the transfected cells showed lower proliferation than the control cells (P < 0.05). After 24 h in culture, the apoptosis rate in miR-129-5p-transfected cells was 3.48 ± 0.38 %, while the rate in control cells was 0.92 ± 0.09 % (P = 0.0028), but the statistical significance was lost after 72 h in culture (P = 0.3180). The invasion and migration of the cells were inhibited after 24 and 72 h in culture when the miR-129-5p expression in Hep-2 cells was upregulated (P = 0.0037 and 0.00383, respectively), while there was no statistically significant difference at 48 h (P = 0.0712). STAT3 expression could be suppressed by the upregulation of miR-129-5p expression. Both the proliferation and migration of tumor cells were suppressed when the level of STAT3 expression was decreased. The apoptosis rate of tumor cells was also increased. Based on these data, we suggest that miR-129-5p may directly inhibit STAT3 expression and play an important role in the development of LSCC.

Entities:  

Keywords:  Apoptosis; Invasion; Laryngeal squamous cells carcinoma; STAT3; miRNA-129-5p

Mesh:

Substances:

Year:  2015        PMID: 26318305     DOI: 10.1007/s13277-015-3969-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.

Authors:  Jung-Hye Choi; Myung-Ju Ahn; Chan-Kum Park; Hong-Xiu Han; Sung-Joon Kwon; Young-Yuel Lee; In-Soon Kim
Journal:  APMIS       Date:  2006-09       Impact factor: 3.205

3.  Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.

Authors:  Ruizhe Shen; Shen Pan; Shengjian Qi; Xiaolin Lin; Shidan Cheng
Journal:  Biochem Biophys Res Commun       Date:  2010-03-21       Impact factor: 3.575

4.  Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro.

Authors:  Chen Huang; Jun Cao; Ke J Huang; Fang Zhang; Tao Jiang; Lin Zhu; Zheng J Qiu
Journal:  Cancer Sci       Date:  2006-10-19       Impact factor: 6.716

5.  Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.

Authors:  Florian R Greten; Christoph K Weber; Tim F Greten; Günter Schneider; Martin Wagner; Guido Adler; Roland M Schmid
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

6.  Survey of MicroRNA expression in pediatric brain tumors.

Authors:  Diane K Birks; Valerie N Barton; Andrew M Donson; Michael H Handler; Rajeev Vibhakar; Nicholas K Foreman
Journal:  Pediatr Blood Cancer       Date:  2010-11-03       Impact factor: 3.167

7.  Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.

Authors:  Ke-Min Cai; Xue-Li Bao; Xu-Hui Kong; Wu Jinag; Ming-Rong Mao; Jiu-Sheng Chu; Yong-Jiu Huang; Xiao-Jun Zhao
Journal:  Int J Mol Med       Date:  2010-04       Impact factor: 4.101

8.  Differential expression of cellular microRNAs in HPV 11, -16, and -45 transfected cells.

Authors:  Anita Dreher; Maria Rossing; Bogumil Kaczkowski; Ditte K Andersen; Therese Juhlin Larsen; Mikael Kronborg Christophersen; Finn Cilius Nielsen; Bodil Norrild
Journal:  Biochem Biophys Res Commun       Date:  2011-07-18       Impact factor: 3.575

9.  Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.

Authors:  Bin Liu; Zhong Ren; Yang Shi; Chao Guan; Zimin Pan; Zhihong Zong
Journal:  Laryngoscope       Date:  2008-11       Impact factor: 3.325

10.  Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.

Authors:  Xu-dong Zhao; Wei Zhang; Hong-jun Liang; Wen-yue Ji
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more
  17 in total

1.  Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial-mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2.

Authors:  Zhenming Jiang; Yuxi Zhang; Xi Chen; Pingeng Wu; Dong Chen
Journal:  Cancer Cell Int       Date:  2019-10-21       Impact factor: 5.722

2.  Tumor suppressor function of miR-129-5p in lung cancer.

Authors:  Ge Li; Jiahang Xie; Jiuhui Wang
Journal:  Oncol Lett       Date:  2019-04-12       Impact factor: 2.967

3.  Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway.

Authors:  Tianyi Liu; Shimin Zong; Yang Jiang; Rui Zhao; Jie Wang; Qingquan Hua
Journal:  J Immunol Res       Date:  2021-12-13       Impact factor: 4.818

Review 4.  MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy.

Authors:  Pei Li; Hui Liu; Zhiyuan Wang; Feng He; Haifeng Wang; Zhi Shi; Ankui Yang; Jin Ye
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

5.  MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2.

Authors:  Dan Yu; Guang-Hong Han; Xue Zhao; Xueshibojie Liu; Kai Xue; Di Wang; Cheng-Bi Xu
Journal:  Cell Oncol (Dordr)       Date:  2019-12-28       Impact factor: 6.730

6.  Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.

Authors:  A Valentino; A Calarco; A Di Salle; M Finicelli; S Crispi; R A Calogero; F Riccardo; A Sciarra; A Gentilucci; U Galderisi; S Margarucci; G Peluso
Journal:  Oncogene       Date:  2017-07-03       Impact factor: 9.867

7.  HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.

Authors:  Lumin Wang; Dongdong Tong; Qingqing Guo; Xiaofei Wang; Fei Wu; Qian Li; Juan Yang; Lingyu Zhao; Yannan Qin; Yingxun Liu; Chen Huang
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

8.  miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer.

Authors:  Jie Wang; Xing-Jun Guo; You-Ming Ding; Jian-Xin Jiang
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

9.  miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.

Authors:  Ailiang Zeng; Jianxing Yin; Yan Li; Rui Li; Zheng Wang; Xu Zhou; Xin Jin; Feng Shen; Wei Yan; Yongping You
Journal:  Cell Death Dis       Date:  2018-03-12       Impact factor: 8.469

10.  MiR-129-5p inhibits glioma cell progression in vitro and in vivo by targeting TGIF2.

Authors:  Yuling Diao; Baozhe Jin; Liyong Huang; Wenke Zhou
Journal:  J Cell Mol Med       Date:  2018-02-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.